Samuel R Denmeade


1985 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Prodrugs Medicine & Life Sciences
Androgens Medicine & Life Sciences
Thapsigargin Medicine & Life Sciences
Castration Medicine & Life Sciences
Prostate Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2018

Bipolar androgen therapy in the treatment of prostate cancer

Denmeade, S. R., Jun 1 2018, In : Clinical Advances in Hematology and Oncology. 16, 6, p. 408-411 4 p.

Research output: Contribution to journalComment/debate

Prostatic Neoplasms

Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise

Krueger, T. E. G., Thorek, D. L. J., Denmeade, S. R., Isaacs, J. T. & Brennen, W. N., Sep 1 2018, In : Stem Cells Translational Medicine. 7, 9, p. 651-663 13 p.

Research output: Contribution to journalReview article

Mesenchymal Stromal Cells
Translational Medical Research
Pharmaceutical Preparations
Stem Cells

Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: A randomized, multicenter, placebo-controlled clinical trial

Paller, C. J. , Zhou, X. C. , Heath, E. I. , Taplin, M. E. , Mayer, T. , Stein, M. N. , Bubley, G. J. , Pili, R. , Hudson, T. , Kakarla, R. , Abbas, M. M. , Anders, N. M. , Dowling, D. , King, S. , Bruns, A. B. , Wagner, W. D. , Drake, C. G. , Antonarakis, E. S. , Eisenberger, M. A. , Denmeade, S. R. & 3 others Rudek, M. A., Rosner, G. L. & Carducci, M. A., Jan 15 2018, In : Clinical Cancer Research. 24, 2, p. 306-315 10 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
Prostatic Neoplasms

PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormones

Kostova, M. B., Brennen, W. N., Lopez, D., Anthony, L., Wang, H., Platz, E. & Denmeade, S. R., Jan 1 2018, (Accepted/In press) In : Prostate.

Research output: Contribution to journalArticle

Peptide Hormones
Prostate-Specific Antigen
Prostatic Neoplasms

PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer

Rogers, O. C., Anthony, L., Rosen, D. M., Brennen, W. N. & Denmeade, S. R., Apr 27 2018, In : Oncotarget. 9, 32, p. 22436-22450 15 p.

Research output: Contribution to journalArticle

Tumor Microenvironment
Serine Proteases
Prostate-Specific Antigen
Prostatic Neoplasms
Peptide Hydrolases